Financials MedMen Enterprises Inc.

Equities

MMEN

CA58507M1077

Other Specialty Retailers

Market Closed - Canadian Securities Exchange 03:12:29 2024-01-05 pm EST 5-day change 1st Jan Change
0.015 CAD -.--% Intraday chart for MedMen Enterprises Inc. -25.00% -25.00%

Valuation

Fiscal Period: Giugno 2018 2019 2020 2021 2022
Capitalization 1 111.5 412.6 77.97 185.7 75.71
Enterprise Value (EV) 1 88.3 652 600.5 671.2 458
P/E ratio -2.23 x -3.21 x -0.23 x -1.04 x -0.34 x
Yield - - - - -
Capitalization / Revenue 2.8 x 3.18 x 0.5 x 1.28 x 0.54 x
EV / Revenue 2.22 x 5.02 x 3.82 x 4.63 x 3.25 x
EV / EBITDA -0.98 x -3.15 x -4.01 x -12.1 x -12.8 x
EV / FCF -1,047,086 x -3,331,914 x -7,377,923 x -15,693,614 x -9,588,165 x
FCF Yield -0% -0% -0% -0% -0%
Price to Book 1.57 x 1.76 x 0.53 x 0.97 x 0.5 x
Nbr of stocks (in thousands) 30,345 172,204 373,361 725,457 1,302,149
Reference price 2 3.675 2.396 0.2088 0.2560 0.0581
Announcement Date 10/25/18 10/28/19 10/16/20 9/24/21 9/9/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Giugno 2017 2018 2019 2020 2021 2022
Net sales 1 2.672 39.78 130 157.1 145.1 140.8
EBITDA 1 -10.82 -89.88 -207 -149.8 -55.49 -35.65
EBIT 1 -12.46 -95.91 -229.1 -192.7 -89.3 -61.3
Operating Margin -466.37% -241.08% -176.29% -122.68% -61.56% -43.53%
Earnings before Tax (EBT) 1 -15.38 -110.7 -263.2 -515.3 -143.6 -175.5
Net income 1 -15.42 -66.65 -79.12 -247.3 -124.1 -195.2
Net margin -577.07% -167.53% -60.88% -157.38% -85.58% -138.62%
EPS - -1.646 -0.7470 -0.9144 -0.2458 -0.1692
Free Cash Flow - -84.33 -195.7 -81.39 -42.77 -47.77
FCF margin - -211.97% -150.57% -51.8% -29.48% -33.92%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/7/18 10/25/18 10/28/19 10/16/20 9/24/21 9/9/22
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales 1 33.78 32 42 39.8
EBITDA 1 -11.8 -12.3 -9.7 -14.6
EBIT 1 -26.41 -26.9 -21.7 -29
Operating Margin -78.2% -84.06% -51.67% -72.86%
Earnings before Tax (EBT) 1 -46.09 -49.5 -41.7 -34.5
Net income 1 -49.7 -13.7 -38.9 -55.3
Net margin -147.13% -42.81% -92.62% -138.94%
EPS 2 -0.1100 -0.0400 -0.0200 -0.0587
Dividend per Share - - - -
Announcement Date 2/16/21 5/11/21 9/23/21 11/9/21
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net Debt 1 13.6 - 239 523 485 382
Net Cash position 1 - 23.2 - - - -
Leverage (Debt/EBITDA) -1.253 x - -1.156 x -3.488 x -8.749 x -10.72 x
Free Cash Flow - -84.3 -196 -81.4 -42.8 -47.8
ROE (net income / shareholders' equity) - -97.3% -140% -2,767% 67.6% 57.9%
ROA (Net income/ Total Assets) - -35% -30.8% -19.1% -10.7% -9.63%
Assets 1 - 190.5 256.6 1,295 1,164 2,027
Book Value Per Share - 2.340 1.360 0.4000 0.2600 0.1200
Cash Flow per Share - 1.690 0.1900 0.0200 0.0200 0.0100
Capex 1 6.22 59.6 125 56.7 6.89 9.04
Capex / Sales 232.99% 149.79% 96.16% 36.08% 4.75% 6.42%
Announcement Date 5/7/18 10/25/18 10/28/19 10/16/20 9/24/21 9/9/22
1USD in Million
Estimates
  1. Stock Market
  2. Equities
  3. MMEN Stock
  4. Financials MedMen Enterprises Inc.